Dare Bioscience Inc. (DARE)
NASDAQ · Healthcare
Dare Bioscience Inc. Shareholder Equity 2012–2025
Dare Bioscience Inc. annual shareholder equity history from 2013 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Dare Bioscience Inc. shareholder equity as of December 31, 2025: 2.8M, a 147.28% decrease year-over-year.
- Dare Bioscience Inc. shareholder equity for 2025 were 2.8M, a 147.28% decrease from 2024.
- Dare Bioscience Inc. shareholder equity for 2024 were -6.0M, a 19.11% increase from 2023.
- Dare Bioscience Inc. shareholder equity for 2023 were -5.0M, a 145.42% decrease from 2022.
- Dare Bioscience Inc. shareholder equity for 2022 were 11.1M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Dare Bioscience Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $3 |
| 2024 | $-6 |
| 2023 | $-5 |
| 2022 | $11 |
| 2021 | $39 |
| 2016 | $-1 |
| 2014 | $45 |
| 2013 | $-94 |
Dare Bioscience Inc. Shareholder Equity — FAQ
Dare Bioscience Inc. (DARE) shareholder equity over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see DARE's shareholder equity history?
The chart and table above show Dare Bioscience Inc.'s shareholder equity by year and by quarter, including the growth rate.